The rupture of the plasma membrane could release inflammatory contents, such as lactate dehydrogenase (LDH), adenosine triphosphate (ATP), and calreticulin (CRT) (Figure 11b–d), which activated the adaptive immune response for tumor immunotherapy. The gene discussed is CALR; the disease is neoplasm.